CYP3A5 and ABCB1 Genes and Hypertension

• Lopez AD , MathersCD, EzzatiM, JamisonDT, MurrayCJ: Global and regional burden of disease and risk factors, 2001, systematic analysis of population health data.Lancet367 , 1747–1757 (2006).
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K , CooperRS, BanegasJR et al.: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.JAMA289 , 2363–2369 (2003).
   PubMed Web of Science ®Google Scholar
• Firmann M , MayorV, Marques-VidalPM et al.: The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome.BMC Cardiovasc. Disord.8 , 6 (2008).
   PubMed Web of Science ®Google Scholar
• Brown MJ : Hypertension and ethnic group.BMJ332 , 833–836 (2006).
   PubMed Web of Science ®Google Scholar
• Bovet P , ShamlayeC, GabrielA, RiesenW, PaccaudF: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.BMC Public Health6 , 9 (2006).
   PubMed Web of Science ®Google Scholar
• Kannel WB , WolfPA, VerterJ, McNamaraPM: Epidemiologic assessment of the role of blood pressure in stroke: the Framingham Study. 1970 [see comments].JAMA276 , 1269–1278 (1996).
   PubMed Web of Science ®Google Scholar
• van der Hoogen PC , FeskensEJ, NagelkerkeNJ, MenottiA, NissinenA, KromhoutD: The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group.N. Engl. J. Med.342 , 1–8 (2000).
   PubMed Web of Science ®Google Scholar
• Flack JM , NeatonJ, GrimmRJ et al.: Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group.Circulation92 , 2437–2445 (1995).
   PubMed Web of Science ®Google Scholar
• Levy D , LarsonMG, VasanRS, KannelWB, HoKKL: The progression from hypertension to congestive heart failure.JAMA275 , 1557–1562 (1996).
   PubMed Web of Science ®Google Scholar
• Klag MJ , WheltonPK, RandallBL et al.: Blood pressure and end-stage renal disease in men.N. Engl. J. Med.334 , 13–18 (1996).
   PubMed Web of Science ®Google Scholar
• Tozawa M , IsekiK, IsekiC, KinjoK, IkemiyaY, TakishitaS: Blood pressure predicts risk of developing end-stage renal disease in men and women.Hypertension41 , 1341–1345 (2003).
   PubMed Web of Science ®Google Scholar
• Lowe LP , GreenlandP, RuthKJ, DyerAR, StamlerR, StamlerJ: Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men.Arch. Intern. Med.158 , 2007–2014 (1998).
   PubMed Web of Science ®Google Scholar
• Din-Dzietham R , LiuY, BieloMV, ShamsaF: High blood pressure trends in children and adolescents in national surveys, 1963 to 2002.Circulation116 , 1488–1496 (2007).
   PubMed Web of Science ®Google Scholar
• Chiolero A , BovetP, ParadisG, PaccaudF: Has blood pressure increased in children in response to the obesity epidemic?Pediatrics119 , 544–553 (2007).
   PubMed Web of Science ®Google Scholar
• Rotimi CN , CooperRS, CaoG et al.: Maximum-likelihood generalized heritability estimate for blood pressure in Nigerian family.Hypertension33 , 874–878 (1999).
   PubMed Web of Science ®Google Scholar
• Abney C , McPeeksMS, OberC: Broad and narrow heritabilities of quantitative traits in a founder population.Am. J. Hum. Genet.68 , 1302–1307 (2001).
   PubMed Web of Science ®Google Scholar
• Harrap SB , StebbingM, HopperJL, HoangHN, GilesGG: Familial patterns of covariation for cardiovascular risk factors in adults. The Victorian Family Heart Study.Am. J. Epidemiol.152 , 704–715 (2000).
   PubMed Web of Science ®Google Scholar
• Kotchen TA , KotchenJM, GrimCE et al.: Genetic determinants of hypertension: identification of candidate phenotypes.Hypertension36 , 7–13 (2000).
   PubMed Web of Science ®Google Scholar
• Levy D , DeStefanoAL, LarsonMG et al.: Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study.Hypertension36 , 477–483 (2000).
   PubMed Web of Science ®Google Scholar
• Adeyemo AA , OmotadeOO, RotimiCN, LukeAH, TayoBO, CooperRS: Heritability of blood pressure in Nigerian families.J. Hypertens.20 , 859–863 (2002).
   PubMed Web of Science ®Google Scholar
• Gu C , BoreckiIB, GagnonJ et al.: Familial resemblance for resting blood pressure with particular reference to racial differences: preliminary analyses from the HERITAGE Family Study.Hum. Biol.70 , 77–90 (1998).
   PubMed Web of Science ®Google Scholar
• Bochud M , BovetP, ElstonRC et al.: High heritability of ambulatory blood pressure in families of East African descent.Hypertension45 , 445–450 (2005).
   PubMed Web of Science ®Google Scholar
• Neal B , MacMahonS, ChapmanN: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists‘ Collaboration.Lancet356 , 1955–1964 (2000).
   PubMed Web of Science ®Google Scholar
• Dickerson JE , HingoraniAD, AshbyMJ, PalmerCR, BrownMJ: Optimisation of antihypertensive treatment by crossover rotation of four major classes.Lancet353 , 2008–2013 (1999).
   PubMed Web of Science ®Google Scholar
• Carretero OA , OparilS: Essential hypertension. Part I: definition and etiology.Circulation101 , 329–335 (2000).
   PubMed Web of Science ®Google Scholar
• Harrap SB : Where are all the blood-pressure genes?Lancet361 , 2149–2151 (2003).
   PubMed Web of Science ®Google Scholar
• Moore JH , WilliamsSM: New strategies for identifying gene–gene interactions in hypertension.Ann. Med.34 , 88–95 (2002).
   PubMed Web of Science ®Google Scholar
• Monti J , PlehmR, SchulzH, GantenD, KreutzR, HubnerN: Interaction between blood pressure quantitative trait loci in rats in which trait variation at chromosome 1 is conditional upon a specific allele at chromosome 10.Hum. Mol. Genet.12 , 435–439 (2003).
   PubMed Web of Science ®Google Scholar
• Sugiyama F , ChurchillGA, HigginsDC et al.: Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci.Genomics71 , 70–77 (2001).
   PubMed Web of Science ®Google Scholar
• Dutil J , EliopoulosV, TremblayJ, HametP, CharronS, DengAY: Multiple quantitative trait loci for blood pressure interacting epistatically and additively on Dahl rat chromosome 2.Hypertension45 , 557–564 (2005).
   PubMed Web of Science ®Google Scholar
• Palijan A , LambertR, DutilJ, SivoZ, DengAY: Comprehensive congenic coverage revealing multiple blood pressure quantitative trait loci on Dahl rat chromosome 10.Hypertension42 , 515–522 (2003).
   PubMed Web of Science ®Google Scholar
• Kardia SL : Context-dependent genetic effects in hypertension.Curr. Hypertens. Rep.2 , 32–38 (2000).
   PubMedGoogle Scholar
• Bochud M , EapCB, ElstonRC et al.: Association of CYP3A5 genotypes with blood pressure and renal function in African families.J. Hypertens.24 , 923–929 (2006).
   PubMed Web of Science ®Google Scholar
• Kuznetsova T , StaessenJA, BrandE et al.: Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension.J. Hypertens.24 , 235–242 (2006).
   PubMed Web of Science ®Google Scholar
• De Wardener HE , McGregorGA: The natriuretic hormone and essential hypertension.Lancet1 , 1450–1454 (1982).
   PubMed Web of Science ®Google Scholar
• Lifton RP : Molecular genetics of human blood pressure variation.Science272 , 676–680 (1996).
   PubMed Web of Science ®Google Scholar
• Meneton P : Comparative roles of the renal apical sodium transport systems in blood pressure control.J. Am. Soc. Nephrol.11 , S135–S139 (2000).
   PubMed Web of Science ®Google Scholar
• Bianchi G , FerrariP, StaessenJA: Adducin polymorphism: detection and impact on hypertension and related disorders.Hypertension45 , 331–340 (2005).
   PubMed Web of Science ®Google Scholar
• Tikhonoff V , KuznetsovaT, StolarzK et al.: β-adducin polymorphisms, blood pressure, and sodium excretion in three European populations.Am. J. Hypertens.16 , 840–846 (2003).
   PubMed Web of Science ®Google Scholar
• Hunt SC , CookNRC, ObermanA et al.: Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension trials of hypertension prevention, Phase II.Hypertension32 , 393–401 (1998).
   PubMed Web of Science ®Google Scholar
• Hunt SC , GeleijnseJM, WuLL, WittemanJC, WilliamsRR, GrobbeeDE: Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene.Am. J. Hypertens.12 , 460–466 (1999).
   PubMed Web of Science ®Google Scholar
• Eap CB , BochudM, ElstonRC et al.: The CYP3A5 and ABCB1 genes encoding drug- and hormone-metabolizing and transporting proteins influence blood pressure and response to treatment, and their effect is modified by salt.Hypertension49 , 1007–1014 (2007).
   PubMed Web of Science ®Google Scholar
• Kurzawski M , PawlikA, GornikW, DrozdzikM: Frequency of common MDR1 gene variants in a Polish population.Pharmacol. Rep.58 , 35–40 (2006).
   PubMed Web of Science ®Google Scholar
• Ameyaw MM , RegateiroF, LiT et al.: MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.Pharmacogenetics11 , 217–221 (2001).
   PubMedGoogle Scholar
• Wang D , JohnsonAD, PappAC, KroetzDL, SadeeW: Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability.Pharmacogenet. Genomics15 , 693–704 (2005).
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarfaty C , OhJM, KimIW et al.: A ‘silent‘ polymorphism in the MDR1 gene changes substrate specificity.Science315 , 525–528 (2007).
   PubMed Web of Science ®Google Scholar
• Siegsmund M , BrinkmannU, SchaffelerE et al.: Association of the P-glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors.J. Am. Soc. Nephrol.13 , 1847–1854 (2002).
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S , BurkO, von Richter O et al.: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA97 , 3473–3478 (2000).
   PubMed Web of Science ®Google Scholar
• Owen A , ChandlerB, BrayPG et al.: Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4.J. Virol.78 , 12022–12029 (2004).
   PubMed Web of Science ®Google Scholar
• Fellay J , MarzoliniC, MeadenER et al.: Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1, a pharmacogenetics study.Lancet359 , 30–36 (2002).
   PubMed Web of Science ®Google Scholar
• Hauser IA , KoziolekM, HopferU, ThevenodF: Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells.Kidney Int.54 , 1139–1149 (1998).
   PubMed Web of Science ®Google Scholar
• Thiebaut F , TsuruoT, HamadaH, GottesmanMM, PastanI, WillinghamMC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proc. Natl Acad. Sci. USA84 , 7735–7738 (1987).
   PubMed Web of Science ®Google Scholar
• Ernest S , RajaramanS, MegyesiJ, Bello-ReussEN: Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney.Nephron77 , 284–289 (1997).
   PubMed Web of Science ®Google Scholar
• Sugawara I , HamadaH, NakahamaM, OkamotoS, TsuruoT, MoriS: Further characterization of the human adrenal-derived P-glycoprotein recognized by monoclonal antibody MRK 16 reacting with only human P-glycoprotein.Jpn J. Cancer Res.80 , 1199–1205 (1989).
   PubMedGoogle Scholar
• Uhr M , HolsboerF, MullerMB: Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both MDR1A and MDR1B P-glycoproteins.J. Neuroendocrinol.14 , 753–759 (2002).
   PubMed Web of Science ®Google Scholar
• Ueda K , OkamuraN, HiraiM et al.: Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.J. Biol. Chem.267 , 24248–24252 (1992).
   PubMed Web of Science ®Google Scholar
• Bello-Reuss E , ErnestS, HollandOB, HellmichMR: Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells.Am. J. Physiol. Cell Physiol.278 , C1256–C1265 (2000).
   PubMed Web of Science ®Google Scholar
• Parker RB , YatesCR, LaizureSC, WeberKT: P-glycoprotein modulates aldosterone plasma disposition and tissue uptake.J. Cardiovasc. Pharmacol.47 , 55–59 (2006).
   PubMed Web of Science ®Google Scholar
• Huang BS , WangH, LeenenFHH: Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats.Am. J. Physiol. Heart Circ. Physiol.288 , H517–H524 (2005).
   PubMed Web of Science ®Google Scholar
• Huang BS , CheungWJ, WangH, TanJ, WhiteRA, LeenenFH: Activation of brain renin–angiotensin–aldosterone system by central sodium in Wistar rats.Am. J. Physiol. Heart Circ. Physiol.291 , H1109–H1117 (2006).
   PubMed Web of Science ®Google Scholar
• Widder JD , GuzikTJ, MuellerCF et al.: Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.Arterioscler. Thromb. Vasc. Biol.27 , 762–768 (2007).
   PubMed Web of Science ®Google Scholar
• Zolk O , JacobiJ, PahlA, FrommMF, SchmiederRE: MDR1 genotype-dependent regulation of the aldosterone system in humans.Pharmacogenet. Genomics17 , 137–144 (2007).
   PubMed Web of Science ®Google Scholar
• Stern N , LustigS, PetrasekD et al.: Cyclosporin A-induced hyperreninemic hypoaldosteronism. A model of adrenal resistance to angiotensin II.Hypertension9 , III31–III35 (1987).
   PubMed Web of Science ®Google Scholar
• Adu D , TurneyJ, MichaelJ, McMasterP: Hyperkalaemia in cyclosporin-treated renal allograft recipients.Lancet2 , 370–372 (1983).
   PubMed Web of Science ®Google Scholar
• Siest G , JeannessonE, Visvikis-SiestS: Enzymes and pharmacogenetics of cardiovascular drugs.Clin. Chim. Acta381 , 26–31 (2007).
   PubMed Web of Science ®Google Scholar
• Vaidyanathan S , JarugulaV, DieterichHA, HowardD, DoleWP: Clinical pharmacokinetics and pharmacodynamics of aliskiren.Clin. Pharmacokinet.47 , 515–531 (2008).
   PubMed Web of Science ®Google Scholar
• Del Moral RG , OlmoA, OsunaA et al.: Role of P-glycoprotein in chronic cyclosporine nephrotoxicity and its relationship to intrarenal angiotensin II deposits.Transplant Proc.30 , 2014–2016 (1998).
   PubMed Web of Science ®Google Scholar
• Koziolek MJ , RiessR, GeigerH, ThevenodF, HauserIA: Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.Kidney Int.60 , 156–166 (2001).
   PubMed Web of Science ®Google Scholar
• Foote CJ , GreerW, KiberdBA et al.: MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.Transplant Proc.38 , 2847–2849 (2006).
   PubMed Web of Science ®Google Scholar
• Liu YT , HaoHP, LiuCX, WangGJ, XieHG: Drugs as CYP3A probes, inducers, and inhibitors.Drug Metab. Rev.39 , 699–721 (2007).
   PubMed Web of Science ®Google Scholar
• Daly AK : Significance of the minor cytochrome P450 3A isoforms.Clin. Pharmacokinet.45 , 13–31 (2006).
   PubMed Web of Science ®Google Scholar
• Kuehl P , ZhangJ, LinY et al.: Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.Nat. Genet.27 , 383–391 (2001).
   PubMed Web of Science ®Google Scholar
• Givens RC , LinYS, DowlingAL et al.: CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.J. Appl. Physiol.95 , 1297–1300 (2003).
   PubMed Web of Science ®Google Scholar
• Schuetz EG , SchuetzJD, GroganWM et al.: Expression of cytochrome P450 3A in amphibian, rat, and human kidney.Arch. Biochem. Biophys.294 , 206–214 (1992).
   PubMed Web of Science ®Google Scholar
• Roberts PJ , RollinsKD, KashubaAD et al.: The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans.Drug Metab. Dispos.36 , 1465–1469 (2008).
   PubMed Web of Science ®Google Scholar
• Ho H , PintoA, HallSD et al.: Association between the CYP3A5 genotype and blood pressure.Hypertension45 , 1–5 (2005).
   Web of Science ®Google Scholar
• Chowbay B , ZhouS, LeeEJ: An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore.Drug Metab. Rev.37 , 327–378 (2005).
   PubMed Web of Science ®Google Scholar
• Ghosh SS , BasuAK, GhoshS et al.: Renal and hepatic family 3A cytochromes P450 (CYP3A) in spontaneously hypertensive rats.Biochem. Pharmacol.50 , 49–54 (1995).
   PubMed Web of Science ®Google Scholar
• Watlington CO , KramerLB, SchuetzEG et al.: Corticosterone 6 β-hydroxylation correlates with blood pressure in spontaneously hypertensive rats.Am. J. Physiol.262 , F927–F931 (1992).
   PubMed Web of Science ®Google Scholar
• Thompson EE , Kuttab-BoulosH, WitonskyD, YangL, RoeBA, DiRA: CYP3A variation and the evolution of salt-sensitivity variants.Am. J. Hum. Genet.75 , 1059–1069 (2004).
   PubMed Web of Science ®Google Scholar
• Pemberton TJ , MehtaNU, WitonskyD et al.: Prevalence of common disease-associated variants in Asian Indians.BMC Genet.9 , 13 (2008).
   PubMed Web of Science ®Google Scholar
• Fromm MF , SchmidtBM, PahlA, JacobiJ, SchmiederRE: CYP3A5 genotype is associated with elevated blood pressure.Pharmacogenet. Genomics15 , 737–741 (2005).
   PubMed Web of Science ®Google Scholar
• Kreutz R , ZuurmanM, KainS, BolbrinkerJ, de Jong PE, Navis G: The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population. Pharmacogenet. Genomics15 , 831–837 (2005).
   PubMed Web of Science ®Google Scholar
• Kivisto KT , NiemiM, SchaeffelerE et al.: CYP3A5 genotype is associated with diagnosis of hypertension in elderly patients: data from the DEBATE study.Am. J. Pharmacogenomics5 , 191–195 (2005).
   PubMedGoogle Scholar
• Langaee TY , GongY, YarandiHN et al.: Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.Clin. Pharmacol. Ther.81 , 386–391 (2007).
   PubMed Web of Science ®Google Scholar
• Kreutz R , ZurcherH, KainS, MartusP, OffermannG, BeigeJ: The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients.Pharmacogenetics14 , 665–671 (2004).
   PubMedGoogle Scholar
• Lieb W , BolbrinkerJ, DoringA et al.: No association of the CYP3A5*1 allele with blood pressure and left ventricular mass and geometry: the KORA/MONICA Augsburg echocardiographic substudy.Clin. Sci. (Lond).111 , 365–372 (2006).
   PubMed Web of Science ®Google Scholar
• Warrington JS , GreenblattDJ, von Moltke LL: Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney. J. Pharmacol. Exp. Ther.309 , 720–729 (2004).
   PubMed Web of Science ®Google Scholar
• Jin Y , WangYH, MiaoJ et al.: Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects.Clin. Pharmacol. Ther.82 , 579–585 (2007).
   PubMed Web of Science ®Google Scholar
• Kamdem LK , HamiltonL, ChengC et al.: Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia.Pharmacogenet. Genomics18 , 507–514 (2008).
   PubMed Web of Science ®Google Scholar
• Schuetz EG , BeckWT, SchuetzJD: Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.Mol. Pharmacol.49 , 311–318 (1996).
   PubMed Web of Science ®Google Scholar
• Burk O , ArnoldKA, GeickA, TegudeH, EichelbaumM: A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression.Biol. Chem.386 , 503–513 (2005).
   PubMed Web of Science ®Google Scholar
• Burk O , KochI, RaucyJ et al.: The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR).J. Biol. Chem.279 , 38379–38385 (2004).
   PubMed Web of Science ®Google Scholar
• Geick A , EichelbaumM, BurkO: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.J. Biol. Chem.276 , 14581–14587 (2001).
   PubMed Web of Science ®Google Scholar
• Lamba J , StromS, VenkataramananR et al.: MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.Clin. Pharmacol. Ther.79 , 325–338 (2006).
   PubMed Web of Science ®Google Scholar
• Hamlyn JM , HamiltonBP, ManuntaP: Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis.J. Hypertens.14 , 151–167 (1996).
   PubMed Web of Science ®Google Scholar
• Brouillard F , TondelierD, EdelmanA, Baudouin-LegrosM: Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.Cancer Res.61 , 1693–1698 (2001).
   PubMed Web of Science ®Google Scholar
• Rautio J , HumphreysJE, WebsterLO et al.: In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates.Drug Metab. Dispos.34 , 786–792 (2006).
   PubMed Web of Science ®Google Scholar

▪ Website

• Supplementary electronic resource data for ‘Concept, Design and Implementation of a Cardiovascular Gene-centric 50K SNP array for Large-scale Genomic Association Studies‘ http://bmic.upenn.edu/cvdsnp/
   Google Scholar